top of page

BackTable / Tumor Board / Topic / Condition

Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) Condition Overview

Learn more on the BackTable Tumor Board Podcast

BackTable is a knowledge resource for physicians by physicians. Get practical advice on Hepatocellular Carcinoma (HCC) and how to build your practice by listening to the BackTable Tumor Board Podcast, reading exclusing BackTable Articles, and following the work of our Contributors.

Ep 9 Principles to Practice: An HCC Tumor Board with Dr. Gabe Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton and Dr. Sid Padia
00:00 / 01:04

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Hepatocellular Carcinoma (HCC) Podcasts

Listen to leading physicians discuss hepatocellular carcinoma (hcc) on the BackTable Tumor Board Podcast. Get tips, tricks, and expert guidance from your peers and level up your practice.

Episode #9

Tumor Board

Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s view of the real case discussions that take place during hepatocellular carcinoma (HCC) tumor boards. Host Dr. Zach Berman sits down with a multidisciplinary team, including Drs. Adam Burgoyne (medical oncologist), Heather Patton (hepatologist), Siddharth Padia (interventional radiologist), and Gabriel Schnickel (transplant and hepatobiliary surgeon).

Episode #8

Tumor Board

Are you seeking to build your reputation and patient base within interventional oncology? In this episode, host Dr. Zachary Berman interviews Dr. Siddarth Padia, Dr. Tyler Sandow, Dr. Kavi Krishnasamy, and Dr. Kevin Burns about their journeys into interventional oncology (IO) and their experiences providing care in different practice settings.

Episode #7

Tumor Board

Is surgery truly the "cure" for hepatocellular carcinoma (HCC), and when is it a viable option? In this episode, Dr. Sabeen Dhand leads a roundtable discussion with interventional radiologist Dr. Siddharth Padia and transplant/hepatobiliary surgeons Dr. John Seal and Dr. Gabriel Schnickel, delving into the complexities of surgical treatments for HCC and the evolving landscape of liver resection and transplantation.

Episode #6

Tumor Board

The process of liver transplantation involves many complexities, and each patient's path to transplant is unique. To offer insider perspectives on this process, Dr. Zachary Berman sits down with transplant and hepatobiliary surgeon Dr. John Seal, as well as transplant hepatologists Dr. Heather Patton and Dr. Steve Young.

Episode #5

Tumor Board

Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to palliative intent. To explore the "grey zone" of treatment goals for intermediate-stage HCC patients, Dr. Sabeen Dhand interviews a panel of experts in the field: medical oncologists Dr. Adam Burgoyne and Dr. Lingling Du, along with interventional radiologists Dr. Kirema Garcia-Reyes and Dr. Zachary Berman.

Episode #4

Tumor Board

For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation can be a curative treatment. With multiple ablation options available and still under investigation, it can be challenging to navigate the differences between them. In this episode, Dr. Tyler Sandow hosts a discussion with interventional radiologists Dr. Kirema Garcia-Reyes, Dr. Sabeen Dhand, and Dr. Kevin Burns on the various ablation options for HCC and when to use each one.

Episode #3

Tumor Board

In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors and chemotherapy, making it an exciting time to be practicing oncology. In this episode, Dr. Tyler Sandow interviews oncology experts about the landscape of advanced hepatocellular carcinoma (HCC) and the current state of immunotherapy treatments. He is joined by medical oncologists Dr. Jonathan Mizrah, Dr. Lingling Du, and Dr. Adam Burgoyne, as well as interventional oncologist Dr. Zachary Berman.

Episode #2

Tumor Board

Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after IRs enter clinical practice. In this episode, Drs. Tyler Sandow and Sabeen Dhand host a roundtable discussion with experts on the dosimetry fundamentals that all Y90 operators should understand. They are joined by interventional radiologists Drs. Zachary Berman, Kirema Garcia-Reyes, and Siddharth Padia, who provide their expert insights.

Episode #1

Tumor Board

Welcome to the first episode of BackTable Tumor Board, and our first recording session at our new in-person studio! Guest host Dr. Tyler Sandow (interventional radiologist) leads a multidisciplinary discussion about patient care coordination in hepatocellular carcinoma (HCC) diagnosis and treatment, with insights from his colleagues at Ochsner Health– Dr. Steven Young (hepatologist), Dr. Jonathan Mizrahi (medical oncologist), and Deondra Bonds-Adams (patient navigator).

Disclaimer: The Materials available on https://www.BackTable.com/ are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg

Podcasts

Principles to Practice: An HCC Tumor Board with Dr. Gabe Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton and Dr. Sid Padia on the BackTable Tumor Board Podcast)
Getting Started in Interventional Oncology: Tips for Starting Your Career with Dr. Sid Padia, Dr. Kevin Burns, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy on the BackTable Tumor Board Podcast)
Surgery for HCC: What’s Its Role Today? with Dr. John Seal, Dr. Gabe Schnickel and Dr. Sid Padia on the BackTable Tumor Board Podcast)
Transplantation for HCC: Who, When & How? with Dr. Heather Patton, Dr. John Seal and Dr. Steven Young on the BackTable Tumor Board Podcast)
Curative Intent Therapies for HCC: Today & Tomorrow with Dr. Kirema Garcia-Reyes, Dr. Kevin Burns, Dr. Sabeen Dhand and Dr. Zach Berman on the BackTable Tumor Board Podcast)
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast)

Articles

Contributors

Dr. Zach Berman on the BackTable Tumor Board Podcast

Dr. Zach Berman

Deondra Bonds-Adams on the BackTable Tumor Board Podcast

Deondra Bonds-Adams

Dr. Adam Burgoyne on the BackTable Tumor Board Podcast

Dr. Adam Burgoyne

Dr. Kevin Burns on the BackTable Tumor Board Podcast

Dr. Kevin Burns

Dr. Sabeen Dhand on the BackTable Tumor Board Podcast

Dr. Sabeen Dhand

Dr. Lingling Du on the BackTable Tumor Board Podcast

Dr. Lingling Du

Related Topics

bottom of page